Nancy Andrews

Nancy Andrews

Director/Miembro de la Junta en CHARLES RIVER LABORATORIES INTERNATIONAL, INC. .

Fortuna: 2 M $ al 30/04/2024

65 años
Commercial Services
Consumer Services
Health Technology

Perfil

Nancy C.
Andrews
is currently serving as the Chairman of the American Academy of Arts & Sciences.
She is also an Independent Director at Charles River Laboratories International, Inc., a Director at Charles River Laboratories, Inc., and a Director at Novartis International AG.
Additionally, she holds the position of Independent Non-Executive Director at Novartis AG since 2015.
Dr. Andrews is also a Director at Maze Therapeutics, Inc. and the Chief Scientific Officer & Executive VP at The Children's Hospital Corp.
She is a Council Member at the National Academy of Sciences and a Member of the National Academy of Medicine (United States) since 2019.
Furthermore, she serves as a Member of the Scientific Management Review Board and the MIT Corp.
(United States).
In her former roles, Dr. Andrews served as the Chairman of The Burroughs Wellcome Fund from 2011 to 2019.
She was also a Director at Duke University Health System, Inc. and a Program Director at Harvard Mit Health Sciences & Technology from 1999 to 2003.
Dr. Andrews held the position of Professor at Duke University from 2007 to 2021 and was a Member-Scientific Management Review Board at the National Institutes of Health from 2014 to 2019.
She served as the President of the American Society for Clinical Investigation and was the Dean of Harvard Medical School from 2003 to 2007.
Additionally, she was the Dean-Emerita & Vice Chancellor-Emerita at Duke University School of Medicine from 2017 to 2021.
Dr. Andrews obtained a doctorate degree from the Massachusetts Institute of Technology and Yale University.
She also holds undergraduate and graduate degrees from Yale University.
Furthermore, she earned a doctorate degree from Harvard Medical School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/12/2023 10 536 ( 0.00% ) 1 M $ 30/04/2024
13/05/2024 3 018 ( 0.01% ) 687 531 $ 30/04/2024

Cargos activos de Nancy Andrews

EmpresasCargoInicio
NOVARTIS AG Director/Miembro de la Junta 01/01/2015
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director/Miembro de la Junta 28/02/2020
Director Técnico/Científico/I+D 01/12/2021
Director/Miembro de la Junta 23/03/2021
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Scientific Management Review Board Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 01/01/2013
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░ -
Todos los cargos activos de Nancy Andrews

Antiguos cargos conocidos de Nancy Andrews.

EmpresasCargoFin
░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Nancy Andrews.

Formación de Nancy Andrews.

Massachusetts Institute of Technology Doctorate Degree
Yale University Graduate Degree
Harvard Medical School Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Nancy Andrews.

Relaciones

100 +

Relaciones de 1er grado

21

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Commercial Services

NOVARTIS AG

Health Technology

Empresas privadas13

Commercial Services

Health Technology

Health Services

Health Services

Government

Miscellaneous

Commercial Services

Commercial Services

Commercial Services

Health Technology

Scientific Management Review Board

Consumer Services

Commercial Services

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA